BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
Today, the evidence base is growing, the results are hard to argue with, and patients across Dubai are discovering why this peptide is rapidly becoming one of the most requested therapies at our clinic
Water Retention and Edema: Excessive growth hormone levels can cause swelling and bloating, leading to discomfort and potential cardiovascular strain
Specifically, it's amino acids 176-191 of the HGH molecule - the part responsible for fat burning without the growth-promoting or insulin-affecting properties of full-length growth hormone
ACD Fetal&Neonatal edition